ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,510Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 70

$979K Total Retail Price of All Prescriptions

Rank: 8 out of 70

491 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 20,919 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
PRAVASTATIN SODIUM 1,652 1,596 10 1 18
METFORMIN HCL 920 904 2 9
ATENOLOL 866 866 3 21
HYDROCHLOROTHIAZIDE 753 739 4 15
PANTOPRAZOLE SODIUM 736 709 5 42
JANUVIA 673 673 6 49
ALPRAZOLAM 661 643 7 60
RANITIDINE HCL 579 560 8 26
PAROXETINE HCL 513 510 9 66
LEVOTHYROXINE SODIUM 499 486 10 2
CRESTOR 482 457 11 45
LISINOPRIL 470 458 12 3
OMEPRAZOLE 464 443 13 4
LOSARTAN POTASSIUM 450 448 14 24
GLIMEPIRIDE 420 414 15 34
AMLODIPINE BESYLATE 369 363 16 5
ALLOPURINOL 359 352 17 31
METOPROLOL TARTRATE 341 313 18 7
FLUTICASONE PROPIONATE 323 308 19 47
ACTONEL 319 317 20 173
ENALAPRIL MALEATE 291 279 21 54
FOLIC ACID 285 285 22 122
TEMAZEPAM 255 246 23 121
FENOFIBRATE 236 236 24 65
SYNTHROID 196 189 25 114
TRADJENTA 190 178 26 211
CLOTRIMAZOLE-BETAMETHASONE 171 169 27 151
DOXAZOSIN MESYLATE 160 147 28 78
CLORAZEPATE DIPOTASSIUM 158 154 29 222
DONEPEZIL HCL 154 142 30 11
FUROSEMIDE 151 145 31 6
VOLTAREN 150 143 32 137
LOSARTAN-HYDROCHLOROTHIAZIDE 148 148 33 82
BENICAR 143 122 34 227
AZITHROMYCIN 141 122 35 40
LIVALO 139 132 36 229
CILOSTAZOL 139 139 36 160
ONGLYZA 137 137 38 231
TRIAMTERENE-HCTZ 137 137 38 81
LANSOPRAZOLE 135 135 40 209
SIMVASTATIN 134 134 41 1
IBANDRONATE SODIUM 129 123 42 234
TAMSULOSIN HCL 129 129 42 29
FINASTERIDE 123 123 44 75
SINGULAIR 114 113 45 85
ATORVASTATIN CALCIUM 113 113 46 27
METOPROLOL SUCCINATE 111 111 47 25
ESCITALOPRAM OXALATE 110 110 48 35
POTASSIUM CHLORIDE 109 109 49 12
CLOPIDOGREL 106 106 50 30
PLAVIX 103 103 51 43
CARVEDILOL 97 97 52 19
LEXAPRO 96 96 53 99
DIGOXIN 88 76 54 41
LORAZEPAM 86 86 55 187
CIPROFLOXACIN HCL 84 75 56 51
TERAZOSIN HCL 84 84 56 112
ACTOS 84 84 56 163
MELOXICAM 83 83 59 39
VERAPAMIL ER 81 80 60 134
MECLIZINE HCL 80 79 61 115
ZETIA 78 78 62 153
VIAGRA 76 76 63 195
PENTOXIFYLLINE 71 71 64 222
NEXIUM 71 71 64 63
DIOVAN 70 60 66 44
ISOSORBIDE MONONITRATE ER 69 69 67 50
BENICAR HCT 69 69 67 279
PRILOSEC OTC 69 69 67 279
NAMENDA 68 68 70 13
WARFARIN SODIUM 66 66 71 10
LEVOFLOXACIN 65 63 72 71
PHENYTOIN SODIUM EXTENDED 63 51 73 118
ZOLPIDEM TARTRATE 63 60 73 23
DICLOFENAC SODIUM 62 61 75 139
AVODART 60 60 76 209
FAMOTIDINE 59 55 77 73
DILTIAZEM ER 59 59 77 189
AMOX TR-POTASSIUM CLAVULANATE 53 50 79 168
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.